欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/3602/003
药品名称
Rivastigmin AbZ 13,3 mg/24 Stunden transdermales Pflaster
活性成分
rivastigmine 27.0 mg
剂型
Transdermal patch
上市许可持有人
AbZ-Pharma GmbH - Geschäftsanschrift - Graf-Arco-Str. 3 D-89079 Ulm
参考成员国 - 产品名称
Germany (DE)
Rivastigmin AbZ 13,3 mg/24 Stunden transdermales Pflaster
互认成员国 - 产品名称
许可日期
2015/05/28
最近更新日期
2024/07/09
药物ATC编码
N06DA03 rivastigmine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common_final_pl_DE3602_V028
Date of last change:2024/09/06
Final SPC
|
common_final_spc_DE3602_V028
Date of last change:2024/09/06
Final Labelling
|
DE3404_01_02_Rivastigmine 4_6_9_5 mg_24 h transdermal patch_OuP _Carton multipack__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3404_01_02_Rivastigmine 4_6_9_5 mg_24 h transdermal patch_OuP _Carton__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3404_03_Rivastigmine 13_3 mg_24 h transdermal patch_OuP _Carton multipack__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3404_03_Rivastigmine 13_3 mg_24 h transdermal patch_OuP _Carton__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3602_01_02_Rivastigmine 4_6_9_5 mg_24 h transdermal patch_OuP _Carton multipack__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3602_01_02_Rivastigmine 4_6_9_5 mg_24 h transdermal patch_OuP _Carton__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3602_03_Rivastigmine 13_3 mg_24 h transdermal patch_OuP _Carton multipack__clean_20180307_renewal
Date of last change:2024/09/06
Final Labelling
|
DE3602_03_Rivastigmine 13_3 mg_24 h transdermal patch_OuP _Carton__clean_20180307_renewal
Date of last change:2024/09/06
Final Product Information
|
final_common_Pl_3602_030
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase